Knopp Neurosciences Adds $6.6 Million

Knopp Neurosciences Inc., a Pittsburgh-based developer of biomarkers and drug therapy for amyotrophic lateral sclerosis, said that current investors have exercised $6.6 million in Series B2 warrants, bringing the company’s total venture capitalization to $27 million. Backers include Saturn Partners, Kramer Capital Partners and LaunchCyte LLC.

North AmericaUSBriefs